Persistence pays off, at least that is the
message from Rountree et al. in the first research article published in Alzheimer’s Research
& Therapy.  This article, ‘Persistent treatment with cholinesterase
inhibitors and/or memantine slows clinical progression of Alzheimer’s disease
(AD)’ reports their findings that persistent
treatment had a
positive impact on Alzheimer’s disease (AD) progression by multiple cognitive
and functional outcome measures.

Alzheimer’s
Research & Therapy publishes basic research with a
translational focus, as well as looking at animal models of disease,
biomarkers, clinical trials, and research into drug discovery and development.
Although the primary focus is Alzheimer’s dementia, the scope will encompass
translational research into other neurodegenerative diseases. 

The
Editors-in-Chief of Alzheimer’s Research & Therapy are Professors Douglas Galasko, Todd Golde, and
Gordon Wilcock, who are supported by an exceptional international Editorial Board.

Submit your next manuscript to Alzheimer’s Research
& Therapy to join the pioneering authors who are publishing in this
exciting journal. For more details about the journal, please visit the journal
information page, or contact the editorial
office. To keep up to date with the latest developments, news and articles
being published in this exciting, please register
to receive regular alerts.

Frances Mulvany
In-house Editor – Alzheimer’s Research & Therapy